Published in J Immunol on November 01, 2004
Why must T cells be cross-reactive? Nat Rev Immunol (2012) 1.88
Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci U S A (2010) 1.63
Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. J Mol Biol (2007) 1.36
Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection. J Virol (2007) 1.32
Coping with loss of perfection in the MHC class I peptide repertoire. Curr Opin Immunol (2008) 1.21
Peptide length determines the outcome of TCR/peptide-MHCI engagement. Blood (2012) 1.13
A comprehensive calorimetric investigation of an entropically driven T cell receptor-peptide/major histocompatibility complex interaction. Biophys J (2007) 1.04
MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors. PLoS Pathog (2010) 0.99
Peptide-dependent conformational fluctuation determines the stability of the human leukocyte antigen class I complex. J Biol Chem (2014) 0.93
The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family. Haematologica (2010) 0.93
Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms. Proc Natl Acad Sci U S A (2012) 0.86
Naturally processed non-canonical HLA-A*02:01 presented peptides. J Biol Chem (2014) 0.86
Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule. J Biol Chem (2013) 0.86
Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough. Front Immunol (2013) 0.84
Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residue. Mol Cell Proteomics (2013) 0.83
The T cell antigen receptor: the Swiss army knife of the immune system. Clin Exp Immunol (2015) 0.82
Structure of HLA-A*1101 in complex with a hepatitis B peptide homologue. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.81
Accurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens. Mol Immunol (2013) 0.80
The saga of MHC-bound peptides: a renaissance for antigen presentation? J Clin Invest (2007) 0.79
Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes. Immunogenetics (2016) 0.75
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature (2011) 6.14
Peroxiredoxins. Biol Chem (2002) 3.61
Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity (2012) 2.23
Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev (2002) 2.02
Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept. Transpl Int (2010) 1.99
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest (2010) 1.96
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol (2007) 1.90
Management of major postsurgical gastroesophageal intrathoracic leaks with an endoscopic vacuum-assisted closure system. Gastrointest Endosc (2009) 1.89
Structure of the molybdopterin-bound Cnx1G domain links molybdenum and copper metabolism. Nature (2004) 1.81
Protective role of beta interferon in host defense against influenza A virus. J Virol (2006) 1.80
The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics. Transpl Int (2009) 1.78
Aftercare for patients with transplanted organs. Dtsch Arztebl Int (2009) 1.72
Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg (2005) 1.69
Novel reporter mouse reveals constitutive and inflammatory expression of IFN-beta in vivo. J Immunol (2009) 1.69
The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity. Ann Transplant (2012) 1.63
Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol (2008) 1.59
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
Development of interleukin-17-producing γδ T cells is restricted to a functional embryonic wave. Immunity (2012) 1.52
Quality of life and functional long-term outcome after partial pancreatoduodenectomy: pancreatogastrostomy versus pancreatojejunostomy. Ann Surg Oncol (2005) 1.52
Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses. J Virol (2007) 1.50
Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha. PLoS One (2009) 1.47
Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus. J Immunol (2013) 1.45
C1-inhibitor for prophylaxis of xenograft rejection after pig to cynomolgus monkey kidney transplantation. Transplantation (2002) 1.45
Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Clin Cancer Res (2004) 1.42
Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res (2008) 1.42
Kidney transplant in children weighing less than 15 kg: donor selection and technical considerations. Transplantation (2002) 1.41
A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation. Transpl Int (2015) 1.39
Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice. Inflamm Bowel Dis (2014) 1.38
Effect of incomplete parathyroidectomy preserving entire parathyroid glands on renal graft function. Arch Surg (2011) 1.38
Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology (2002) 1.38
Potentiation of epithelial innate host responses by intercellular communication. PLoS Pathog (2010) 1.31
Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response. Cell Rep (2013) 1.28
Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS One (2010) 1.28
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation (2002) 1.27
Type I interferon drives tumor necrosis factor-induced lethal shock. J Exp Med (2009) 1.25
Salmonella-allies in the fight against cancer. J Mol Med (Berl) (2010) 1.24
Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology (2002) 1.22
Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood (2009) 1.21
Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol (2007) 1.21
Temporal and spatial resolution of type I and III interferon responses in vivo. J Virol (2010) 1.18
The cholesterol-dependent cytolysin listeriolysin O aggregates rafts via oligomerization. Cell Microbiol (2005) 1.18
Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial. Surgery (2010) 1.15
Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia (2013) 1.15
The multiple mechanisms of Ca2+ signalling by listeriolysin O, the cholesterol-dependent cytolysin of Listeria monocytogenes. Cell Microbiol (2007) 1.14
Effects of type I interferons on Friend retrovirus infection. J Virol (2006) 1.14
Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling. Clin Cancer Res (2005) 1.14
Synergistic and differential modulation of immune responses by Hsp60 and lipopolysaccharide. J Biol Chem (2006) 1.12
UBD, a downstream element of FOXP3, allows the identification of LGALS3, a new marker of human regulatory T cells. Lab Invest (2006) 1.12
Production of IFN-β during Listeria monocytogenes infection is restricted to monocyte/macrophage lineage. PLoS One (2011) 1.12
Tryparedoxin peroxidase of Leishmania donovani: molecular cloning, heterologous expression, specificity, and catalytic mechanism. Arch Biochem Biophys (2002) 1.11
Critical role for miR-181a/b-1 in agonist selection of invariant natural killer T cells. Proc Natl Acad Sci U S A (2013) 1.07
IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer. Virchows Arch (2003) 1.06
Assessment of toluene/biphenyl dioxygenase gene diversity in benzene-polluted soils: links between benzene biodegradation and genes similar to those encoding isopropylbenzene dioxygenases. Appl Environ Microbiol (2006) 1.06
Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene. J Gen Virol (2009) 1.04
Melithiazol biosynthesis: further insights into myxobacterial PKS/NRPS systems and evidence for a new subclass of methyl transferases. Chem Biol (2003) 1.04
Pinpointing biphenyl dioxygenase residues that are crucial for substrate interaction. J Bacteriol (2003) 1.04
Kinetics and redox-sensitive oligomerisation reveal negative subunit cooperativity in tryparedoxin peroxidase of Trypanosoma brucei brucei. Biol Chem (2003) 1.04
The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. J Immunol (2005) 1.03
Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol (2008) 1.00
Synthesis of sucrose analogues and the mechanism of action of Bacillus subtilis fructosyltransferase (levansucrase). Carbohydr Res (2006) 1.00
Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes Infect (2009) 0.99
Absence of IFN-beta impairs antigen presentation capacity of splenic dendritic cells via down-regulation of heat shock protein 70. J Immunol (2009) 0.99
Sterol and pH interdependence in the binding, oligomerization, and pore formation of Listeriolysin O. Biochemistry (2007) 0.98
In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells. Blood (2010) 0.98
Improving live attenuated bacterial carriers for vaccination and therapy. Int J Med Microbiol (2007) 0.97
Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J Virol (2012) 0.97
IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J Immunol (2005) 0.95
Bacteria-mediated DNA transfer in gene therapy and vaccination. Expert Opin Biol Ther (2004) 0.95
Systematic delineation of a calmodulin peptide interaction. J Mol Biol (2004) 0.94
Mast cells initiate early anti-Listeria host defences. Cell Microbiol (2007) 0.94
Maintenance of peritoneal B-1a lymphocytes in the absence of the spleen. J Immunol (2004) 0.93
Essential role of CCL2 in clustering of splenic ERTR-9+ macrophages during infection of BALB/c mice by Listeria monocytogenes. Infect Immun (2006) 0.93
Effects of BisGMA on glutathione metabolism and apoptosis in human gingival fibroblasts in vitro. Biomaterials (2004) 0.93
B-1a cells are imprinted by the microenvironment in spleen and peritoneum. Eur J Immunol (2007) 0.93
Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection. Liver Transpl (2013) 0.92
Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis. Acta Neuropathol (2015) 0.91
Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium. FEMS Immunol Med Microbiol (2011) 0.91
Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc Natl Acad Sci U S A (2010) 0.91
Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites. Environ Microbiol (2012) 0.91
An intrinsic propensity of murine peritoneal B1b cells to switch to IgA in presence of TGF-β and retinoic acid. PLoS One (2013) 0.91
Murine pulmonary infection with Listeria monocytogenes: differential susceptibility of BALB/c, C57BL/6 and DBA/2 mice. Microbes Infect (2005) 0.91
Siglec-G regulates B1 cell survival and selection. J Immunol (2010) 0.91
3D CT modeling of hepatic vessel architecture and volume calculation in living donated liver transplantation. Eur Radiol (2003) 0.90
In-vivo expression profiling of Pseudomonas aeruginosa infections reveals niche-specific and strain-independent transcriptional programs. PLoS One (2011) 0.89
Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients. Liver Transpl (2009) 0.89
The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens. Eur J Immunol (2010) 0.89
Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis. Scand J Gastroenterol (2006) 0.89
Transformation of mouse fibroblasts alters the induction pattern of type I IFNs after virus infection. Biochem Biophys Res Commun (2005) 0.89
Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency. Liver Transpl (2003) 0.89
Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitro. BMC Cancer (2012) 0.89
SIGN-R1+MHC II+ cells of the splenic marginal zone--a novel type of resident dendritic cells. J Leukoc Biol (2011) 0.89
Somatic hypermutation in peritoneal B1b cells. Mol Immunol (2009) 0.88
Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic. Nucleic Acids Res (2011) 0.88
Functional transfer of eukaryotic expression plasmids to mammalian cells by Listeria monocytogenes: a mechanistic approach. J Gene Med (2005) 0.88
Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance. Oncoimmunology (2012) 0.87
Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. J Virol (2013) 0.87